Advancing Nuclear Medicine
TRP Summit 2020
- Exploring new radiopharmaceuticals
- Sourcing radiopharmaceuticals supply to secure trials
- Developing radionuclide therapy using molecular imaging
Digital Summit
The Targeted Radiopharmaceuticals (TRP) Summit is an industry-led platform, that discusses challenges and opportunities faced by developers of theranostic radio ligand therapies. Topics such as the identification and validation of new targets and ways to improve the current clinical design methodologies will be discussed by speakers and panels.
Entering the 4th year of the Targeted Radiopharmaceuticals EU Summit the flagship event of the TRP series is growing further encompassing critical new topics including:
• commercialisation,
• applications of software tools in discovery, clinical trials and imaging,
• radiopharmacy,
• patient/doctor education.
About FIELD-LAB
FIELD-LAB is a drug discovery facility that will help you to speed up the development and market launch of new nuclear drugs for cancer treatment. Through supply of small batches of radio chemicals and radio pharmaceuticals, we meet the need of Bio Pharma scientists and start-up ventures for research materials. This will drive both their ambitions to develop a new drug.
- Medical isotope in high demand
- Beta-emitter
- Independent supply from in-house FIELD-LAB process
- High quality
- Chemotherapeutic compound (cisplatin) with Pt-195m integrated by synthesis
- For in-human use
- Chemotherapeutic function unaltered
- Beta-emitter with limited recoil, and a single alpha emission in the decay chain
- Ideal half-life (~10 hrs.)
- Reliable supply
Practical information
When: Tuesday 6 until Thursday 8, December 2022
Where: Amsterdam
If you wish to learn more about the speakers, the programme or registration, please check the TRP Summit website.
Contactform
We look forward to meet you in Amsterdam!
If you want to get in touch about the TRP Summit or want to learn more about FIELD-LAB and Advancing Nuclear Medicine, please leave your contact information in this form. We will reach out to you as soon as possible.